Compare Kotak Healthcare Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.34 | 2.27 |
NAV | ₹12.74 | ₹272.02 |
Fund Started | 20 Nov 2023 | 01 Aug 2005 |
Fund Size | ₹467.92 Cr | ₹1101.63 Cr |
Exit Load | 0.5% for redemption within 30 Days | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.34
2.27
NAV
₹12.74
₹272.02
Fund Started
20 Nov 2023
01 Aug 2005
Fund Size
₹467.92 Cr
₹1101.63 Cr
Exit Load
0.5% for redemption within 30 Days
Exit load of 1% if redeemed within 30 days.
1 Year | -4.68% | -1.69% |
3 Year | - | 22.59% |
5 Year | - | 14.30% |
1 Year
-4.68%
-1.69%
3 Year
-
22.59%
5 Year
-
14.30%
Equity | 96.25% | 99.40% |
Cash | 3.75% | 0.59% |
Equity
96.25%
99.40%
Cash
3.75%
0.59%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.86% |
Max Healthcare Institute Ltd. | 7.26% |
JB Chemicals & Pharmaceuticals Ltd. | 6.26% |
Divi's Laboratories Ltd. | 5.46% |
Cipla Ltd. | 4.84% |
Lupin Ltd. | 4.28% |
Apollo Hospitals Enterprise Ltd. | 3.99% |
Fortis Healthcare Ltd. | 3.78% |
Acutaas Chemicals Ltd. | 3.28% |
Jubilant Pharmova Ltd. | 3.21% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 20 Nov 2023 | 01 Aug 2005 |
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
20 Nov 2023
01 Aug 2005